STATE OF WISCONSIN
Controlled Substances Board
IN THE MATTER OF RULE-MAKING PROCEEDINGS BEFORE THE
CONTROLLED SUBSTANCES BOARD
AFFIRMATIVE ACTION ORDER OF THE
CONTROLLED SUBSTANCES BOARD
FINDINGS
1. On November 12, 2015, the Department of Justice, Drug Enforcement Administration published its final rule in the Federal Register placing eluxadoline into schedule IV of the federal Controlled Substances Act. The scheduling action is effective December 17, 2015.
2. The Controlled Substances Board did not receive an objection to similarly treating eluxadoline as a schedule IV under ch. 961, Stats. within 30 days of the date of publication in the federal register of the final order designating eluxadoline as a controlled substance. 3. The Controlled Substances Board will promulgate a final rule, without making the determinations or findings required by ss. 961.11(1), (1m), (1r) and (2) or s. 961.19 and omitting the notice of proposed rule making, designating eluxadoline as a schedule IV controlled substance. ORDER
Pursuant to s. 961.11(4), Stats., the Controlled Substances Board by affirmative action similarly treats eluxadoline under chapter 961, Stats. by creating the following: CSB 2.48 Addition of eluxadoline to schedule IV. Section 961.20 (4) (cm), Stats., is created to read: 961.20 (4) (cm) Eluxadoline, including any of its isomers, and salts of isomers.
This order shall take effect on November 21, 2016 to allow for publication in the Administrative Register. The order expires upon promulgation of a final rule.
Dated 11-15-16 /s/ Doug Englebert
Doug Englebert, Chair
Controlled Substances Board
